CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy

被引：2
作者：
Wilton-Clark, Harry [1 ]
Yokota, Toshifumi [1 ]
机构：
[1] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada
来源：
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 2023年 / 30卷
关键词：
D O I：
10.1016/j.omtm.2023.08.013
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：500 / 501
页数：2
相关论文
共 50 条
  • [21] Exon-skipping therapy for Duchenne muscular dystrophy
    Nakamura, Akinori
    Takeda, Shin'ichi
    NEUROPATHOLOGY, 2009, 29 (04) : 494 - 501
  • [22] Exon-skipping advances for Duchenne muscular dystrophy
    Echevarria, Lucia
    Aupy, Philippine
    Goyenvalle, Aurelie
    HUMAN MOLECULAR GENETICS, 2018, 27 (R2) : R163 - R172
  • [23] Clinical trials of exon skipping in Duchenne muscular dystrophy
    Mendell, Jerry R.
    Sahenk, Zarife
    Rodino-Klapac, Louise R.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (09): : 683 - 690
  • [24] Development of Antisense-Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy
    Heemskerk, Hans
    de Winter, Christa L.
    van Ommen, Gert-Jan B.
    van Deutekom, Judith C. T.
    Aartsma-Rus, Annemieke
    OLIGONUCLEOTIDE THERAPEUTICS, 2009, 1175 : 71 - 79
  • [25] Optimization of therapeutic antisense-mediated exon skipping for Duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    Heemskerk, Hans
    De Winter, Christa
    Janson, Anneke
    Van Ommen, Gert-Jan
    Van Deutekom, Judith
    HUMAN GENE THERAPY, 2007, 18 (10) : 983 - 984
  • [26] The Potential of Exon Skipping for Treatment for Duchenne Muscular Dystrophy
    Partridge, Terence
    JOURNAL OF CHILD NEUROLOGY, 2010, 25 (09) : 1165 - 1170
  • [27] Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
    Lim, Kenji Rowel Q.
    Yoon, Chantal
    Yokota, Toshifumi
    JOURNAL OF PERSONALIZED MEDICINE, 2018, 8 (04):
  • [28] CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy
    Mbakam, Cedric Happi
    Lamothe, Gabriel
    Tremblay, Guillaume
    Tremblay, Jacques P.
    NEUROTHERAPEUTICS, 2022, 19 (03) : 931 - 941
  • [29] CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne muscular dystrophy
    Guiraud, S.
    Dastidar, S.
    Mazed, F.
    Amor, F.
    Ralu, M.
    de Cian, A.
    Richard, I.
    Ronzitti, G.
    Tedesco, F. S.
    Amendola, M.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A34 - A34
  • [30] CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy
    Cedric Happi Mbakam
    Gabriel Lamothe
    Guillaume Tremblay
    Jacques P. Tremblay
    Neurotherapeutics, 2022, 19 : 931 - 941
12345